Blockchain Registration Transaction Record

340B Program Fails Patients: $66B Growth, Rising Medical Debt Exposed

ADAP Advocacy exposes how the $66B 340B Drug Pricing Program fails patients despite growth, with hospitals pursuing aggressive medical debt collection against vulnerable Americans.

This investigation matters because medical debt affects millions of Americans, often leading to financial ruin and preventing people from seeking necessary healthcare. The 340B Program was created to help vulnerable patients access affordable medications and care, but if hospitals benefiting from billions in program savings are simultaneously aggressively pursuing patients for debt, it represents a systemic failure that undermines healthcare affordability and accessibility for those most in need. This exposes how well-intentioned programs can be distorted, potentially worsening the very problems they were designed to solve.